Bremen-Mitte Clinic
| Germany | Turkey | Austria | |
| Removal of liver cancer | from $30,000 | from $10,800 | from $40,000 |
| Radiofrequency ablation of the liver | from $12,000 | from $3,500 | from $12,000 |
| Liver resection | from $30,000 | from $11,700 | from $35,000 |
| Chemoembolization of the liver | from $18,000 | from $7,500 | from $16,000 |
| Chemotherapy for liver cancer | from $1,139 | from $1,800 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Metastases in the liver treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Metastases in the liver treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Metastases in the liver treatment journey.
Dr. Bernd Hertenstein brings of expertise in clinical oncology, specializing in advanced treatments for liver metastases at Bremen-Mitte Clinic.
The doctor is a Professor and Doctor of Medical Sciences specializing in oncosurgery. As an author of numerous scientific publications, the doctor contributes significantly to the medical literature. A member of the Association of Hepatobiliary and Pancreatic Surgery, the doctor is actively involved in advancing surgical practices. Additionally, the doctor serves as a teacher at the Hanover School of Medicine, sharing expertise with future medical professionals. Currently, the doctor holds the position of Chief Physician of the Department of General, Visceral and Oncological Surgery at the Bremen-Mitte Hospital.
Dr. Rainer Porschen is the Director of the Clinic for Internal Medicine at Bremen-Ost Clinic. He ranks among the top 100 doctors in Germany for gastrointestinal lesion treatment. Dr. Porschen develops national guidelines for esophageal cancer treatment. He specializes in gastrointestinal tumors, Crohn's disease, and pancreatic cancer.